drug · antibody
IXIFI
Marketedupdated 6mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5Antibody drug with a maximum clinical stage of Approval (across all indications), with 8 approved and 44 investigational indications.
targets
Tumor necrosis factor
all catalysts(4)
approval · 4
Dec 13, 2017
approval
$PFE28.86-0.10%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Jan 16, 2020
approval
$PFE28.86-0.10%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Dec 26, 2023
approval
$PFE28.86-0.10%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
Oct 9, 2025
approval
$PFE28.86-0.10%
IXIFI (INFLIXIMAB-QBTX) — FDA approval
IXIFI
→
News(2)
- Celltrion picks up another Kaigene autoimmune antibody for up to $580.5MCelltrion has licensed a preclinical antibody targeting autoimmune conditions from Maryland-based biotech Kaigene in a deal worth up to $580.5 million, marking another step in the South Korean drug…fiercebiotech · 26d ago
- Hospital and pharmaceutical prices are smothering America’s businessesWorkers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care industry’s high and inscrutable prices.stat · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that